HBV mutation literature information.


  Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China.
 PMID: 28751727       2017       Scientific reports
Result: In addition, the other six mutations types (P127T, A128V, G130E, T131P, M133I and D144N) were not yet identified as VEMs, and D144N was a newly identified mutation (Table 3).
Table:
Discussion: Additionally, a small amount of P127T, A128V, G130E, T131P/N, M133T/I, F134L and D144N mutations was observed in our study, including the less frequent T131N/M133T double mutations.


  Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India.
 PMID: 28591184       2017       PloS one
Discussion: The presence of sA128V substitution, an immune escape mutation, is often associated with HBV/D2 and is considered as a subgenotype specific change.


  HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy.
 PMID: 28303969       2017       Scientific reports
Result: Among these, only one RT-variant, rtH124N and 6 Result: At 48 week of TDF therapy, the frequencies of rtM204I, rtL80I, sS45A, sT118V, sW196L and sA128V continued to be significantly reduced from baseline in responders, although an increase in frequency of the substitution rtV278I was noted in the HBV clones of the responders during this observational period (Table 5).


  The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy.
 PMID: 28300730       2017       Antiviral therapy
Abstract: Except for the combination of sP120T+sA128V, other double combinations (n=11) were only detected in the NA treatment group, and nine of these combinations in the treatment group were detected in HBV variants without antiviral resistance mutations.


  HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
 PMID: 27354181       2017       Antiviral therapy
Abstract: In particular, the 'a' determinant surface gene mutations (sT125S, sA128V, sQ129H/R, sT131I, sC137S, sT143M, sD144D/E, sG145R, sT148P) and the majority of clustered/multiple as well as drug selected immune escape HBsAg mutations were more prevalent


  Molecular epidemiology of hepatitis B virus isolated from Bangladesh.
 PMID: 27652086       2016       SpringerPlus
Abstract: A significant n
Result: Several mutations were observed in 'a' determinant region of S gene such as, T118V, T125M, T126I, P127T, A128V and T/S143L/M according to different genotypes of HBV (Table 1).
Table: Ala128Val


  Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.
 PMID: 24835494       2014       PloS one
Table: A128V


  Molecular characterization of HBV strains circulating among the treatment-naive HIV/HBV co-infected patients of eastern India.
 PMID: 24587360       2014       PloS one
Abstract: Furthermore, the frequently occurring mutations in the major hydrophilic loop of the S gene include the T125M, A128V and M133I/L.
Result: Moreover, 93.3% of the HBV/D2 strains had T118V (14/15) whereas all the HBV/D2 isolates were associated with A128V.
Discussion:


  Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China.
 PMID: 22500577       2012       Virology journal
Result: D99N, Q101R/H, L109I, I110N, T115S, S117T, P120S, K122R, S126T/A, P127H, A128V, Q129R/H/L, G130E, T131N/A, M133T/L/S, F134R/I/L, T143M, A159V, F161Y, W163G, E164G, V168A


  Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
 PMID: 19207682       2009       Journal of gastroenterology and hepatology
Abstract: A128V & T143M mutations were observed in 5 of 13 (38.4%) subjects and A128V & P127S in 2 of 13 (15.3%) patients (P = 0.385).
Abstract: A128V mutation was seen in two (15.3%) subjects with D2 genotype, while T143M mutation was seen in three (23.07%) subjects with A1genotype.



Browser Board

 Co-occurred Entities




   Filtrator